Cellectar Biosciences CEO Jim Caruso was chosen to present at the Rodman & Renshaw 17th Annual Global Investment Conference, taking place Sept. 10 in New York City, the organization announced recently.

“The Rodman conference continues to support emerging companies and provides a tremendous venue to communicate our respective value propositions,” Caruso said in a statement. “We look forward to presenting the company and our PDC delivery platform, which possesses the ability to link diverse oncologic payloads for targeted delivery to a broad range of cancer and cancer stem cell targets.”

The conference brings growth companies together with a wide audience of financial and strategic investors.